Non-small cell lung cancer (NSCLC) is the most common form of lung cancer. It arises as abnormal cells develop in or around the lungs and form tumors. Most cases of NSCLC are caused by smoking ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window When it comes to small cell lung cancer (SCLC), there are a lot of highs and lows. For instance, it has a fairly low ...

Ticiana Leal, MD, discusses how recently approved targeted therapies for small cell lung cancer (SCLC) significantly enhance ...

Non-small-cell lung cancer (NSCLC) is the most common type of cancer affecting the lungs. The diverse types of NSCLC are characterized by cancer cells that grow and spread in different ways.

Ying Cheng, M.D., from Jilin Cancer Hospital in Changchun, China, and colleagues conducted a phase 3 trial involving patients with limited-stage small cell lung cancer who did not have disease ...

Individual results/experiences may vary. He is an expert when it comes to a challenging type of lung cancer. It's called ROS1+ non-small cell lung cancer (NSCLC), and it's known for being aggressive ...

Patients with limited-stage SCLC were randomly assigned to receive durvalumab with or without tremelimumab or placebo as ...

Ticiana Leal, MD, discusses how in cases of extensive stage small cell lung cancer (ES-SCLC) that progress within 6 months of ...

Approximately 213,380 new cases of non-small-cell lung cancer (NSCLC) were estimated to occur in the USA in 2007, which caused 160,390 NSCLC-related deaths. The majority of patients will be ...

Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune Lua® for ...